Company: MYGN
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000899923-25-000019
Chunk: 237

Company: MYRIAD GENETICS INC
Filing Date: 2025-02-28
Form: 10-K
Item: Item 8
Chunk 237
---
 Consolidated Statements of Operations (iii) Consolidated Statements of Comprehensive Loss, (iv) Consolidated Statements of Stockholders’ Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements. Inline XBRL Instance Document – Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.X104Cover Page Interactive Data File (embedded within the Inline XBRL document)X

(+)    Management contract or compensatory plan arrangement.

Item 16.    FORM 10-K SUMMARY

None.

111

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 28, 2025.

MYRIAD GENETICS, INC.By:/s/ Paul J. DiazPaul J. DiazPresident and Chief Executive Officer

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated below and on the dates indicated.

SignaturesTitleDatePresident, Chief Executive Officer and Director (Principal Executive Officer)By:/s/ Paul J. DiazFebruary 28, 2025Paul J. DiazChief Financial Officer (Principal Financial Officer)By:/s/ Scott J. LefflerFebruary 28, 2025Scott J. LefflerChief Accounting Officer (Principal Accounting Officer)By:/s/ Natalie MunkFebruary 28, 2025Natalie MunkBy:/s/ S. Louise PhanstielChair of the BoardFebruary 28, 2025S. Louise PhanstielBy:/s/ Paul BisaroDirectorFebruary 28, 2025Paul BisaroBy:/s/ Heiner DreismannDirectorFebruary 28, 2025Heiner Dreismann, Ph.D.By:/s/ Rashmi KumarDirectorFebruary 28, 2025Rashmi KumarBy:/s/ Lee N. NewcomerDirectorFebruary 28, 2025Lee N. Newcomer, M.D.By:/s/ Colleen F. ReitanDirectorFebruary 28, 2025Colleen F. ReitanBy:/s/ Daniel M. SkovronskyDirectorFebruary